Related Experiment Video
Updated: Apr 28, 2026
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Transcatheter closure of residual postinfarction ventricular septal defect after dehiscence of surgical patch repair
Abdelfatah Abdelazim Elasfar1, Muhammad Adil Soofi, Tarek Seifaw Kashour
1Dr. Abdelfatah Elasfar, Department of Adult Cardiology,, Prince Salman Heart Center,, King Fahad Medical City,, Riyadh 59046,, Saudi Arabia, T: +966501852566, F: +966112889999 Ext 11113, elasfar_egy@hotmail.com.
Insights
Transcatheter closure successfully treated a residual ventricular septal defect (VSD) after surgical repair failure. This minimally invasive approach offers a viable option for complex post-infarction VSD cases.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Ventricular septal defect (VSD) is a serious complication following myocardial infarction.
- Standard treatment involves surgical repair and revascularization.
- Percutaneous closure is typically for high-risk surgical candidates or failed surgery.
Observation:
- A patient developed a residual VSD after surgical patch dehiscence for a post-infarction VSD.
- This presented a complex clinical scenario requiring alternative treatment.
Findings:
- Successful transcatheter closure of the residual VSD was achieved using an Amplatzer muscular VSD device.
- The procedure demonstrated a favorable outcome with over 3.5 years of follow-up.
Implications:
- Transcatheter closure is a safe and effective alternative for managing residual post-infarction VSDs after surgical complications.
- This approach expands treatment options for patients with complex cardiac defects.
- Highlights the potential of device-based interventions in managing post-myocardial infarction complications.
Abstract:
Ventricular septal defect (VSD) is a life-threatening complication of transmural myocardial infarction. Urgent surgical repair and concomitant revascularization are the standard of care. Percutaneous catheter-based closure techniques have been reserved for patients with a high-risk surgery or a failed surgical procedure with residual shunting. This case report demonstrates the successful transcatheter closure of residual VSD using the Amplatzer muscular VSD device (Amplatzer, Minnesota, USA) after surgical patch dehiscence for postinfarction VSD and 3-and-a-half years' post-intervention follow-up.
